Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients
Open Access
- 1 January 1997
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 21 (1) , 9-16
- https://doi.org/10.1016/s0145-2126(96)00053-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic responseInternational Journal of Cancer, 1994
- Design of human interleukin‐4 antagonists inhibiting interleukin‐4‐dependent and interleukin‐13‐dependent responses in T‐cells and B‐cells with high efficiencyEuropean Journal of Biochemistry, 1994
- Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.The Journal of Experimental Medicine, 1994
- Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitroBritish Journal of Haematology, 1993
- Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.The Journal of Experimental Medicine, 1992
- Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cellsBlood, 1992
- Flow cytometric detection of the mitochondrial BCL‐2 protein in normal and neoplastic human lymphoid cellsCytometry, 1992
- Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemiaBlood, 1991
- Response patterns of purified myeloma cells to hematopoietic growth factorsBlood, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989